AGM Information • Dec 23, 2025
AGM Information
Open in ViewerOpens in native device viewer
(incorporated and registered in England and Wales under number 04115341)
Notice is hereby given that the Annual General Meeting ("AGM") of Baronsmead Second Venture Trust plc (the "Company") will be held at Saddlers' Hall, 40 Gutter Lane, London, EC2V 6BR at 1.30pm on Thursday, 19 March 2026 to consider the proposed resolutions as set out in the Notice of AGM on pages 7 to 8 of this document.
The Manager will deliver a presentation at 11.30am followed by lunch and refreshments at 12.30pm. Shareholders are invited to attend an introductory presentation by the Company Chair, Ms Sarah Fromson, followed by a Q&A session from 1.30pm.
The formal business of the Company's AGM will commence at 2.00pm.
Important information:
If you are in any doubt as to any aspect of the proposals referred to in this document or as to the action you should take, you should seek advice from your stockbroker, solicitor/attorney, accountant, central securities depository participant, banker or other independent professional adviser.
If you have sold or otherwise transferred all of your shares, please pass this document together with the accompanying form of proxy, as soon as possible to the purchaser or transferee, or to the person who arranged the sale or transfer, so that they can deliver the documents to the person who now holds the shares.
A shareholder may appoint one or more proxies to exercise all or any of their rights to attend, speak and vote at the meeting, provided that each proxy is appointed to exercise the rights attached to a different ordinary share or ordinary shares held by that shareholder. A proxy need not be a member of the Company. To be valid, any form of proxy or other instrument appointing a proxy must be received by post or (during normal business hours only) by hand at the Company's Registrar, at the address shown on the form of proxy, or in the case of shares held through CREST, via the CREST system no later than 2.00pm on 17 March 2026. Electronic proxy voting is available for this meeting. Should a shareholder wish to appoint a proxy electronically, such proxy appointment must be registered electronically via the Company's website https://baronsmead2-agm.city-proxyvoting.uk.
I am pleased to enclose the Company's Notice of AGM, which will be held on Thursday, 19 March 2026 at 1.30pm at Saddlers' Hall, 40 Gutter Lane, London, EC2V 6BR. The Notice of AGM, which follows this letter, sets out the business to be considered at the meeting. The purpose of this letter is to explain certain elements of that business to you.
The Board recognises that the Company's AGM represents an important forum for shareholders to ask questions and understands that attending in person may not be possible for all who wish to attend. We encourage all shareholders, whether or not they propose to attend the AGM, to exercise their votes by submitting their proxy electronically or by post no later than 2.00pm on 17 March 2026. Shareholders who wish to appoint a proxy are recommended to appoint the Chair of the AGM as their proxy. All valid proxy votes will be included in the polls to be taken at the meeting.
Your votes do matter. Proxy instructions (which explain how to lodge proxies electronically) are set out below.
The Manager will deliver a presentation at 11.30am followed by lunch and refreshments at 12.30pm. Shareholders are invited to attend an introductory presentation by the Company Chair, Ms Sarah Fromson, followed by a Q&A session from 1.30pm.
Shareholders are invited to submit questions to the Chair in advance of the AGM via email at c[email protected] or by contacting Gresham House Investor Relations via telephone on 020 7382 0999 by no later than 2.00pm on 17 March 2026. We endeavour to publish responses to the questions received in advance on our website, ahead of the proxy voting deadline.
The Directors are required to present the Strategic report, Directors' report, Auditor's report and the financial statements for the year ended 30 September 2025 to the meeting. These are contained in the Company's Annual Report and Financial Statements for the year ended 30 September 2025 (the "2025 Annual Report").
The Board proposes a final dividend of 2.25 pence per share in respect of the year ended 30 September 2025. If approved, the recommended final dividend will be paid on 24 March 2026 to all ordinary shareholders who are on the register of members on 27 February 2026. The shares will be marked ex-dividend on 26 February 2026.
Under section 420 of the Companies Act 2006 (the "Act"), the directors must prepare an annual report detailing the remuneration of the directors and a statement by the chair of the remuneration committee (together, the "Directors' Remuneration Report"). The Act also requires that a resolution be put to shareholders each year for their approval of that report. The Directors' Remuneration Report can be found on pages 55 to 60 of the 2025 Annual Report. Resolution 3 is an advisory vote.
In line with the AIC Code of Corporate Governance, the Nomination Committee has agreed that all Directors will stand for re-election on an annual basis. Therefore, Sarah Fromson, Adriana Stirling, Graham McDonald and Tim Farazmand will retire and being eligible, offer themselves for re-election.
The Board confirms that the performance of each Director seeking re-election continues to be effective and that each Director demonstrates commitment to their role. The Board believes that it is therefore in the best interests of shareholders that each Director be re-elected.
The Directors also believe that the Board includes an appropriate balance of skills, experience and knowledge. Full biographies of all Directors standing for election and re-election are set out on pages 5 to 6 of this document.
Resolutions 8 and 9– To re-appoint BDO LLP as Auditor of the Company, to hold office until the conclusion of the next general meeting at which the accounts are laid before the Company and to authorise the Audit & Risk Committee to determine the remuneration of BDO LLP
At each meeting at which the Company's accounts are presented to its members, the Company is required to appoint an Auditor to serve until the next AGM. The Board, on the recommendation of the Audit & Risk Committee, recommends the reappointment of BDO LLP. Resolution 9 gives authority to the Audit & Risk Committee to determine the Auditor's remuneration.
The authority proposed under Resolution 10 will authorise the Directors, until the conclusion of the AGM held in 2027 or 15 months from the date of passing this resolution, whichever is earlier, to allot shares in the Company or grant rights to subscribe for or convert any security into shares in the Company up to an aggregate nominal amount of £20,820,380 representing 50 per cent of the issued share capital of the Company (excluding treasury shares), as at 22 December 2025. Any consequent increase in the size of the Company will, in the opinion of the Directors, be in the interests of shareholders generally. Any issue proceeds will be available for investment in line with the Company's investment policy and may be used to purchase ordinary shares of the Company.
The Directors intend to use this authority for the purposes described under Resolution 11.
Resolution 11 renews and extends, subject to the passing of Resolution 10, the Directors' authority to allot equity securities for cash without pre-emption rights in certain circumstances. This resolution will authorise the Directors, until the date falling 15 months after the date of the passing of the resolution or, if earlier, the conclusion of the next AGM of the Company, to issue ordinary shares for cash without pre-emption rights applying of: (i) up to an aggregate nominal amount representing 30 per cent of the Company's issued share capital (excluding shares held in treasury) as at the date of the passing of the resolution pursuant to one or more offers for subscription (for illustrative purposes only; had Resolution 11 been passed as at the date of this notice, this authority would have applied to 124,922,280 shares, being 30 per cent of the Company's current issued share capital (excluding shares held in treasury)); (ii) up to an aggregate nominal amount representing 10 per cent of the Company's issued share capital (excluding shares held in treasury) as at the date of the passing of the resolution pursuant to a dividend reinvestment scheme (which may be at a discount to NAV); and (iii) up to an aggregate nominal amount representing 10 per cent of the Company's issued share capital (excluding shares held in treasury) as at the date of the passing of the resolution (which may be at a discount to NAV) for allotments from time to time (for illustrative purposes only; had Resolution 11 been passed as at the date of this notice, this authority would have applied to 41,640,760 shares, being 10 per cent of the Company's current issued share capital excluding treasury shares).
This power will be exercised only if, in the opinion of the Directors, it would be in the best interests of shareholders as a whole.
The current authority of the Company to make market purchases of up to approximately 14.99 per cent of its issued share capital, granted at last year's AGM expires shortly. Resolution 12 seeks renewal of such authority until the next AGM (or the expiry of 15 months after the passing of the resolution if earlier). The price paid for shares will not be less than the nominal value nor more than the maximum amount permitted to be paid in accordance with the rules of the Financial Conduct Authority in force as at the date of purchase. This power will be exercised only if, in the opinion of the Directors, a repurchase would be in the best interests of shareholders as a whole. Any shares repurchased under this authority will either be cancelled or held in treasury at the discretion of the Board for future re-sale in appropriate market conditions.
The authority sought would replace the authority previously given to the Directors. The maximum number of ordinary shares authorised to be purchased pursuant to the authority represents approximately 14.99 per cent of the total number of ordinary shares in issue as at the date of the passing of this resolution (excluding any ordinary shares held in treasury).
Under the Act, the notice period required for all general meetings of the Company is 21 clear days. AGMs will always be held on at least 21 clear days' notice, but shareholders can approve a shorter notice period for other general meetings.
The Board believes that it is in the best interests of shareholders of the Company to have the ability to call meetings on no less than 14 clear days' notice should a matter require urgency. The Board is therefore proposing Resolution 13 to approve the reduction in the minimum notice period from 21 clear days to 14 clear days for all general meetings other than AGMs. The Directors do not intend to use less than 21 clear days' notice unless immediate action is required.
The Directors believe that the resolutions contained within the Notice of AGM are in the best interests of the Company and shareholders as a whole and unanimously recommend that shareholders vote in favour of them, as the Directors intend to do in respect of their beneficial shareholdings. As at 22 December 2025, the total beneficial shareholdings held by the Directors were 394,757 ordinary shares, which represented 0.09 per cent of the total voting rights.
If you would like to vote on the resolutions but will not be attending the AGM, you may appoint a proxy:
Alternatively, if you hold your shares in CREST, you can appoint a proxy via the CREST system.
Notice of your appointment of a proxy should reach the Company's Registrar, The City Partnership (UK) Ltd at the address shown on the proxy form, by no later than 2.00pm on 17 March 2026.
If you hold your shares through a nominee service, please contact the nominee service provider regarding the process for appointing a proxy.
Yours sincerely,
Sarah Fromson
Chair
Sarah is an experienced, independent non-executive who has served on a variety of boards and committees, after a varied career in the asset and wealth management industry. She is a non-executive board member of Boston-based Arrowstreet Capital Partners and is also a Pension Trustee Director of Genome Research Pensions Trustee Limited and Wellcome Trust Pensions Trustee Limited. She chairs the Cambridge University Endowment Fund Investment Advisory Board and also serves on the board of Quilter Investors Ltd, a subsidiary of Quilter plc. In March 2023, Sarah became an Advisory Member of the Investment Committee to Calouste Gulbenkian Foundation, a Lisbon-based entity. Sarah retired from her executive role as Head of Risk at Wellcome Trust in 2019 and as Chair of JP Morgan Global Emerging Markets Income Trust plc in 2022. Sarah was previously Chief Investment Risk Officer at RBS Asset Management (formerly Coutts).
Sarah has a range of experience for her role as Chair of the Board and Chair of the Nomination Committee. Her background includes non-executive roles on various boards and committees, and in varied roles within the asset and wealth management industry, all providing the necessary skills for her contribution and leadership of the Board.
Graham has spent almost 40 years in banking and private equity. His previous executive role was Global Head of Private Equity and Venture Capital at Aberdeen Standard Investments. Prior to that he was responsible for the global private equity and venture capital businesses in Aberdeen Asset Management, SWIP, Lloyds Bank and HBoS. He is Strategic Advisor to Par Equity LLP. Graham stepped down from his position as Chair of Continulus Limited in September 2023 and as advisor to Arcano Capital Partners and Vedra Partners in April 2023 and December 2022, respectively.
Graham has over 40 years of experience as a Non-Executive Director in private equity and venture capital businesses. His expertise enhances the Board's skills and helps ensure effective oversight, challenge and evaluation of the Company, and is relevant in his role as the Senior Independent Director.
Tim Farazmand has spent 35 years in private equity. His last full-time role was as a Managing Director at LDC, the private equity arm of Lloyds Bank. He previously worked for 3i Group Plc and Royal Bank of Scotland Private Equity. He was chair of the British Venture Capital Association (BVCA) for the 2014-2015 term. He currently chairs the Palatine Impact Fund, is a Non Executive Director of Pantheon International Plc and BBB Investment Holdings Ltd, and serves on the advisory boards of Beechbrook Capital and Pitalia Capital.
Tim has varied experience and sector knowledge of private equity and brings his unique insight and perspective to all Board debates. His past experience and other directorships also underpin his expertise when chairing the Management Engagement & Remuneration Committee.
Adriana is a qualified chartered accountant and developed extensive organisational and anti-financial crime technical expertise whilst working for PwC for over 17 years, leading client engagements across both the financial and non-financial service industries, spanning the public and private sectors. In 2014, Adriana became the Managing Director of a private family office and has overall responsibility for the investment and operational aspects of the office, including managing significant shareholder positions in several unquoted companies.
Adriana serves as a Non-Executive Director and Chair of the Audit & Risk Committee. As a qualified accountant, she brings a wealth of experience in both the financial and non-financial service industries, which is pertinent to her responsibilities as Chair of the Committee.
Notice is hereby given that the Annual General Meeting of Baronsmead Second Venture Trust plc will be held on Thursday, 19 March 2026 at 1.30pm at Saddlers' Hall, 40 Gutter Lane, London, EC2V 6BR, to consider and, if thought fit, to pass the following resolutions, of which resolutions 1 to 10 will be proposed as ordinary resolutions; this means that for each of those ordinary resolutions to be passed, more than half of the votes cast must be in favour. Resolutions 11 to 13 will be proposed as special resolutions; this means that for each of those resolutions to be passed, at least three-quarters of the votes cast must be in favour.
Voting will be done by way of a poll.
THAT, the Directors of the Company be and are hereby generally and unconditionally authorised in accordance with Section 551 of the Companies Act 2006 (the "Act"), to exercise all the powers of the Company to allot shares of 10p each in the capital of the Company (the "Ordinary Shares") and to grant rights to subscribe for or to convert any security into Ordinary Shares ("Rights") up to an aggregate nominal amount of £20,820,380 equivalent to 208,203,800 Ordinary Shares (being 50 per cent of the issued Ordinary share capital of the Company on 22 December 2025 (excluding Treasury shares)(being the latest practicable date prior to the publication of this Notice of Meeting)), such authority to apply in substitution for all previous authorities pursuant to Section 551 of the Act and to expire (unless previously revoked, varied, renewed or extended by the Company in general meeting) at the conclusion of the AGM held in 2027 or 15 months from the date of passing this resolution, whichever is earlier save that the Company may, at any time such expiry, make any offer and enter into any agreement which would, or might, require Ordinary Shares to be allotted or rights to subscribe for or to convert any security into Ordinary Shares to be granted after authority given by this resolution expired and the Directors may allot Ordinary Shares or grant Rights to subscribe for or convert securities into Ordinary Shares in pursuance of such offer or agreement as if the authority conferred by this resolution had not expired.
THAT, subject to the passing of resolution 10 set out in the notice of this meeting and in substitution for all subsisting authorities to the extent unused, the Directors be and are hereby empowered, pursuant to sections 570 and 573 of the Companies Act 2006 (the "Act"), to allot equity securities (as defined in section 560 of the Act) for cash pursuant to the authority given pursuant to resolution 10 set out in the notice of this meeting, or by way of a sale of treasury shares, as if section 561(1) of the Act did not apply to any such allotment, provided that this power shall be limited to:
(a) the allotment of equity securities up to an aggregate nominal amount representing 30 per cent of the issued share capital of the Company (excluding treasury shares), as at the date of passing of this resolution pursuant to one or more offers for subscription;
(c) the maximum price which may be paid for an Ordinary Share is an amount equal to the higher of:
(i) 105 per cent of the average of the middle market value for an Ordinary Share taken from the London Stock Exchange daily official list for the five business days immediately preceding the day on which such Ordinary Share is to be purchased; and
By order of the Board
Gresham House Asset Management Ltd Company Secretary
22 December 2025
Registered Office: 5 New Street Square, London, EC4A 3TW
The following notes explain your general rights as a shareholder and your right to attend and vote at this AGM or to appoint someone else to vote on your behalf.
Telephone +44 (0)1484 240910.
Email [email protected]
Post The City Partnership (UK) Ltd
The Mending Rooms Park Valley Mills Meltham Road
Huddersfield – HD4 7BH
(b) if they do not purport to exercise the power in the same way as each other, the power is treated as not exercised.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.